共有 50 笔近期内部人交易记录记录，涉及 PhaseBio Pharmaceuticals, Inc. (PHAS), 包括 35 笔买入 和 13 笔卖出. 内部人买入总额为 $1.07M 内部人卖出总额为 $421.77K.
近期活跃的重要内部人包括 Harrigan Edmund, Loewy Caroline M, Hutson Nancy J. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — PHAS
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2023-05-19 |
Harrigan Edmund |
Director |
期权行权 |
3,750 |
- |
- |
- |
| 2023-05-19 |
Loewy Caroline M |
Director |
期权行权（卖出） |
3,750 |
- |
- |
- |
| 2023-05-19 |
Hutson Nancy J |
Director |
期权行权（卖出） |
3,750 |
- |
- |
- |
| 2023-05-19 |
Van Den Broek Richard |
Director |
期权行权（卖出） |
3,750 |
- |
- |
- |
| 2023-05-19 |
Thorp Clay |
Director |
期权行权 |
3,750 |
- |
- |
- |
| 2023-05-19 |
Humphries William D. |
Director |
期权行权（卖出） |
2,538 |
- |
- |
- |
| 2023-05-19 |
Sapir Alex |
Director |
期权行权（卖出） |
3,750 |
- |
- |
- |
| 2022-10-25 |
New Enterprise Associates 13 Lp |
Director |
知情卖出 |
1,784,109 |
$0.15 |
$262.26K |
4,857,525 |
| 2022-05-20 |
Mow Jonathan P |
Chief Executive Officer |
限制性股票授予 (RSU) |
10,918 |
$0.68 |
$7.44K |
132,502 |
| 2022-05-20 |
Sharp John P |
Chief Financial Officer |
限制性股票授予 (RSU) |
6,026 |
$0.68 |
$4.11K |
65,767 |
| 2022-05-20 |
Arnold Susan Elizabeth |
SVP, Technical Operations |
限制性股票授予 (RSU) |
10,917 |
$0.68 |
$7.44K |
41,236 |
| 2022-05-20 |
Hanson Kristopher |
SVP and General Counsel |
限制性股票授予 (RSU) |
4,831 |
$0.68 |
$3.29K |
8,463 |
| 2022-05-20 |
Burkhardt Glen |
SVP of Human Resources |
知情卖出 |
11,248 |
$0.79 |
$8.89K |
- |
| 2022-05-20 |
Birchall Jonathan |
Chief Commercial Officer |
限制性股票授予 (RSU) |
20,000 |
$0.68 |
$13.63K |
20,000 |
| 2022-05-19 |
Harrigan Edmund |
Director |
限制性股票授予 (RSU) |
3,750 |
- |
- |
3,750 |
| 2022-05-19 |
Loewy Caroline M |
Director |
限制性股票授予 (RSU) |
3,750 |
- |
- |
3,750 |
| 2022-05-19 |
Hutson Nancy J |
Director |
限制性股票授予 (RSU) |
3,750 |
- |
- |
3,750 |
| 2022-05-19 |
Van Den Broek Richard |
Director |
限制性股票授予 (RSU) |
3,750 |
- |
- |
3,750 |
| 2022-05-19 |
Thorp Clay |
Director |
限制性股票授予 (RSU) |
3,750 |
- |
- |
3,750 |
| 2022-05-19 |
Humphries William D. |
Director |
限制性股票授予 (RSU) |
3,750 |
- |
- |
3,750 |
| 2022-05-19 |
Sapir Alex |
Director |
限制性股票授予 (RSU) |
3,750 |
- |
- |
3,750 |
| 2022-05-19 |
Humphries William D. |
Director |
限制性股票授予 (RSU) |
2,538 |
- |
- |
2,538 |
| 2022-02-24 |
Mow Jonathan P |
Chief Executive Officer |
限制性股票授予 (RSU) |
82,500 |
- |
- |
82,500 |
| 2022-02-24 |
Sharp John P |
Chief Financial Officer |
限制性股票授予 (RSU) |
24,750 |
- |
- |
24,750 |
| 2022-02-24 |
Lee John Sang |
Chief Medical Officer |
限制性股票授予 (RSU) |
24,750 |
- |
- |
24,750 |
| 2022-02-24 |
Arnold Susan Elizabeth |
SVP, Technical Operations |
限制性股票授予 (RSU) |
18,750 |
- |
- |
18,750 |
| 2022-02-24 |
Hanson Kristopher |
VP, Head of Legal |
限制性股票授予 (RSU) |
18,750 |
- |
- |
18,750 |
| 2022-02-24 |
Burkhardt Glen |
VP, Human Resources |
限制性股票授予 (RSU) |
18,750 |
- |
- |
18,750 |
| 2022-02-24 |
Birchall Jonathan |
Chief Commercial Officer |
限制性股票授予 (RSU) |
11,250 |
- |
- |
11,250 |
| 2021-11-19 |
Mow Jonathan P |
Chief Executive Officer |
限制性股票授予 (RSU) |
5,623 |
$2.01 |
$11.3K |
172,473 |
| 2021-11-19 |
Sharp John P |
Chief Financial Officer |
限制性股票授予 (RSU) |
2,017 |
$2.01 |
$4.05K |
59,741 |
| 2021-11-19 |
Arnold Susan Elizabeth |
SVP, Technical Operations |
限制性股票授予 (RSU) |
2,559 |
$2.01 |
$5.14K |
30,319 |
| 2021-11-19 |
Hanson Kristopher |
VP, Head of Legal |
限制性股票授予 (RSU) |
1,545 |
$2.01 |
$3.11K |
3,632 |
| 2021-11-19 |
Burkhardt Glen |
VP, Human Resources |
知情卖出 |
5,766 |
$2.37 |
$13.67K |
- |
| 2021-11-08 |
Hutson Nancy J |
Director |
期权行权（卖出） |
7,400 |
$3.15 |
$23.31K |
- |
| 2021-11-08 |
Birchall Jonathan |
Officer |
未知 |
- |
- |
- |
- |
| 2021-11-08 |
Birchall Jonathan |
Chief Commercial Officer |
限制性股票授予 (RSU) |
250,000 |
$3.37 |
$842.5K |
250,000 |
| 2021-11-05 |
Hutson Nancy J |
Director |
期权行权（卖出） |
24,860 |
$2.26 |
$56.18K |
2,256 |
| 2021-11-03 |
Mow Jonathan P |
Chief Executive Officer |
期权行权（卖出） |
20,000 |
$1.24 |
$24.8K |
108,767 |
| 2021-11-03 |
Sharp John P |
Chief Financial Officer |
期权行权 |
7,500 |
$1.68 |
$12.6K |
57,724 |
| 2021-09-14 |
Humphries William D. |
Director |
未知 |
- |
- |
- |
- |
| 2021-09-14 |
Humphries William D. |
Director |
限制性股票授予 (RSU) |
28,000 |
$2.80 |
$78.4K |
28,000 |
| 2021-08-27 |
Mow Jonathan P |
Chief Executive Officer |
期权行权（卖出） |
20,000 |
$1.24 |
$24.8K |
128,767 |
| 2021-08-18 |
Thorp Clay |
Director |
知情买入 |
10,000 |
$3.00 |
$30K |
32,943 |
| 2021-08-18 |
Hutson Nancy J |
Director |
知情买入 |
3,000 |
$3.08 |
$9.24K |
4,000 |
| 2021-08-18 |
Hutson Nancy J |
Director |
知情买入 |
3,000 |
$3.08 |
$9.24K |
4,000 |
| 2021-08-03 |
Sharp John P |
Chief Financial Officer |
限制性股票授予 (RSU) |
7,500 |
$1.68 |
$12.6K |
50,224 |
| 2021-08-03 |
Sharp John P |
Chief Financial Officer |
期权行权 |
7,500 |
$1.68 |
$12.6K |
50,224 |
| 2021-07-12 |
Arnold Susan Elizabeth |
VP, Preclinical and Chem |
期权行权（卖出） |
4,519 |
$1.74 |
$7.86K |
- |
| 2021-07-12 |
Arnold Susan Elizabeth |
VP, Preclinical and Chem |
限制性股票授予 (RSU) |
4,519 |
$1.74 |
$7.86K |
27,760 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
